Proto Labs, Inc. cash flow to debt ratio of 2.45K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Proto Labs, Inc.'s free cash flow has decreased 13.11% from $68.66M last year to $59.66M, signaling decreasing performance

Proto Labs, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

Proto Labs, Inc.'s debt has decreased relative to shareholder equity from 0.01 last year to 0.00 today, signaling strengthened financials

Proto Labs, Inc. has a net cash position, so leverage is healthy.

Interest expense is not separately reported in Proto Labs, Inc.'s latest filing, so interest coverage cannot be calculated.

Proto Labs, Inc.'s profit margin has increased (64.13%) in the last year from 3.31% to 5.44%, signaling increasing performance

Proto Labs, Inc.'s short-term assets of $233.54M exceed its short-term liabilities of $67.00M

Proto Labs, Inc.'s return on assets of 3.85% is lower than the 5.00% threshold, indicating inefficient asset utilization

Proto Labs, Inc.'s return on equity of 4.49%, is lower than 15.00%, indicating bad performance

Proto Labs, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Proto Labs, Inc. had positive net income in 4 out of 5 years, indicating stable and consistent earnings

Proto Labs, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Proto Labs, Inc. has a free cash flow yield of 2.80%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Proto Labs, Inc.'s yearly earnings has increased 28.01% since last year from $16.59M to $21.24M, signaling increasing performance

Proto Labs, Inc.'s yearly revenue has increased 6.44% since last year from $500.89M to $533.13M, signaling increasing performance

ROIC 3.93% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Proto Labs, Inc.'s 3-year revenue CAGR of 2.96% is positive, indicating growing revenue over the past 3 years

Proto Labs, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Proto Labs, Inc. had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity

Proto Labs, Inc. is overvalued relative to its fair value price of 33.72 based on Discounted Cash Flow model

Proto Labs, Inc. has an earnings yield of 1.42%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Proto Labs, Inc. is overvalued relative to its fair value price of 23.57 based on EBITDA multiple model

Proto Labs, Inc. has an EV/EBITDA ratio of 30.96x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Proto Labs, Inc. is overvalued relative to its fair value price of 13.98 based on Earnings Fair Value model

Proto Labs, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Proto Labs, Inc. has a price-to-book ratio of 3.10x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Proto Labs, Inc. has a price-to-sales ratio of 3.82x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue